Dimensional Fund Advisors’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $86.5M | Buy |
|
|||||
|
2025
Q1 | $82.5M | Buy |
|
|||||
|
2024
Q4 | $75.8M | Sell |
|
|||||
|
2024
Q3 | $94.2M | Buy |
|
|||||
|
2024
Q2 | $85.2M | Buy |
|
|||||
|
2024
Q1 | $65M | Buy |
|
|||||
|
2023
Q4 | $68M | Buy |
|
|||||
|
2023
Q3 | $56M | Sell |
|
|||||
|
2023
Q2 | $56.2M | Buy |
|
|||||
|
2023
Q1 | $59.7M | Buy |
|
|||||
|
2022
Q4 | $59.9K | Buy |
|
|||||
|
2022
Q3 | $48.1M | Buy |
|
|||||
|
2022
Q2 | $46.5M | Buy |
|
|||||
|
2022
Q1 | $42.7M | Buy |
|
|||||
|
2021
Q4 | $48.8M | Buy |
|
|||||
|
2021
Q3 | $40.6M | Buy |
|
|||||
|
2021
Q2 | $39.5M | Buy |
|
|||||
|
2021
Q1 | $33.6M | Buy |
|
|||||
|
2020
Q4 | $37.6M | Buy |
|
|||||
|
2020
Q3 | $32.3M | Buy |
|
|||||
|
2020
Q2 | $48M | Buy |
|
|||||
|
2020
Q1 | $31.6M | Buy |
|
|||||
|
2019
Q4 | $31.6M | Buy |
|
|||||
|
2019
Q3 | $23.8M | Buy |
|
|||||
|
2019
Q2 | $29M | Buy |
|
|||||
|
2019
Q1 | $29.3M | Buy |
|
|||||
|
2018
Q4 | $26.4M | Buy |
|
|||||
|
2018
Q3 | $28M | Buy |
|
|||||
|
2018
Q2 | $20.9M | Sell |
|
|||||
|
2018
Q1 | $18.1M | Buy |
|
|||||
|
2017
Q4 | $18M | Buy |
|
|||||
|
2017
Q3 | $18.3M | Buy |
|
|||||
|
2017
Q2 | $17.3M | Buy |
|
|||||
|
2017
Q1 | $16.5M | Buy |
|
|||||
|
2016
Q4 | $15M | Buy |
|
|||||
|
2016
Q3 | $16.1M | Buy |
|
|||||
|
2016
Q2 | $12.5M | Buy |
|
|||||
|
2016
Q1 | $13M | Buy |
|
|||||
|
2015
Q4 | $16.1M | Buy |
|
|||||
|
2015
Q3 | $15.4M | Sell |
|
|||||
|
2015
Q2 | $20.1M | Buy |
|
|||||
|
2015
Q1 | $16.6M | Buy |
|
|||||
|
2014
Q4 | $11.8M | Buy |
|
|||||
|
2014
Q3 | $9.18M | Sell |
|
|||||
|
2014
Q2 | $10.4M | Sell |
|
|||||
|
2014
Q1 | $11.6M | Sell |
|
|||||
|
2013
Q4 | $12M | Buy |
|
|||||
|
2013
Q3 | $12.3M | Buy |
|
|||||
|
2013
Q2 | $9.43M | Buy |
|